Det fanns dock en oförklarad ökning i incidensen av benfrakturer (6% i orlistatgruppen jämfört med 2, 8% i placebogruppen). ###>However, there was an unexplained increase in the incidence of bone fractures (6% versus 2.8% in the orlistat and placebo groups, respectively).